Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesPierluigi Tricoci, Kenneth W. Mahaffey, Harvey D. White et al.|New England Journal of Medicine|2011Cited by 753
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophySharla M. Birch, Joe N. Kornegay, Michael W. Lawlor et al.|Science Translational Medicine|2023Cited by 68
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophyMichael J. Struharik, Xiaoqing Pan, Amanda K. Bettis et al.|UNC Libraries|2024Cited by 0